Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Venge

Showing results (381-390 of 401) with videos related to

Pageof 41
Sort By:
The American Journal of Medicine|January 1, 1989
Neutrophil and eosinophil involvement of the small bowel in patients with celiac disease and Crohn's disease: studies on the secretion rate and immunohistochemical localization of granulocyte granule constituentsR Hällgren, J F Colombel, R Dahl, et al.
The American Review of Respiratory Disease|November 1, 1993
Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitisM Linden, J B Rasmussen, E Piitulainen, et al.
The Journal of Allergy and Clinical Immunology|February 15, 2001
Inflammatory cell and epithelial characteristics of perennial allergic and nonallergic rhinitis with a symptom history of 1 to 3 years' durationK Amin, J Rinne, T Haahtela, et al.
Heart (British Cardiac Society)|July 16, 2005
FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery diseaseB Lagerqvist, E Diderholm, B Lindahl, et al.
Journal of the American College of Cardiology|March 18, 1999
Low molecular weight heparin (dalteparin) as adjuvant treatment of thrombolysis in acute myocardial infarction--a pilot study: biochemical markers in acute coronary syndromes (BIOMACS II)G Frostfeldt, G Ahlberg, G Gustafsson, et al.
The Journal of Allergy and Clinical Immunology|October 1, 1991
Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthmaJ Bousquet, P Chanez, J Y Lacoste, et al.
The European Respiratory Journal|October 1, 1988
Oral N-acetylcysteine reduces selected humoral markers of inflammatory cell activity in BAL fluid from healthy smokers: correlation to effects on cellular variablesA Eklund, O Eriksson, L Håkansson, et al.
British Journal of Haematology|September 13, 2001
Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's diseaseD Molin, M Fischer, Z Xiang, et al.
The European Respiratory Journal|December 5, 1997
Effect of 1 year daily treatment with 400 microg budesonide (Pulmicort Turbuhaler) in newly diagnosed asthmaticsK Osterman, M Carlholm, J Ekelund, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 1, 1996
Complete heparin-coated cardiopulmonary bypass and low heparin dose reduce complement and granulocyte activationE Ovrum, E Fosse, T E Mollnes, et al.
Pageof 41

Showing results (381-390 of 401) with videos related to

Sort By:
Pageof 41
The American Journal of Medicine|January 1, 1989
Neutrophil and eosinophil involvement of the small bowel in patients with celiac disease and Crohn's disease: studies on the secretion rate and immunohistochemical localization of granulocyte granule constituentsR Hällgren, J F Colombel, R Dahl, et al.
The American Review of Respiratory Disease|November 1, 1993
Airway inflammation in smokers with nonobstructive and obstructive chronic bronchitisM Linden, J B Rasmussen, E Piitulainen, et al.
The Journal of Allergy and Clinical Immunology|February 15, 2001
Inflammatory cell and epithelial characteristics of perennial allergic and nonallergic rhinitis with a symptom history of 1 to 3 years' durationK Amin, J Rinne, T Haahtela, et al.
Heart (British Cardiac Society)|July 16, 2005
FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery diseaseB Lagerqvist, E Diderholm, B Lindahl, et al.
Journal of the American College of Cardiology|March 18, 1999
Low molecular weight heparin (dalteparin) as adjuvant treatment of thrombolysis in acute myocardial infarction--a pilot study: biochemical markers in acute coronary syndromes (BIOMACS II)G Frostfeldt, G Ahlberg, G Gustafsson, et al.
The Journal of Allergy and Clinical Immunology|October 1, 1991
Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthmaJ Bousquet, P Chanez, J Y Lacoste, et al.
The European Respiratory Journal|October 1, 1988
Oral N-acetylcysteine reduces selected humoral markers of inflammatory cell activity in BAL fluid from healthy smokers: correlation to effects on cellular variablesA Eklund, O Eriksson, L Håkansson, et al.
British Journal of Haematology|September 13, 2001
Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's diseaseD Molin, M Fischer, Z Xiang, et al.
The European Respiratory Journal|December 5, 1997
Effect of 1 year daily treatment with 400 microg budesonide (Pulmicort Turbuhaler) in newly diagnosed asthmaticsK Osterman, M Carlholm, J Ekelund, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 1, 1996
Complete heparin-coated cardiopulmonary bypass and low heparin dose reduce complement and granulocyte activationE Ovrum, E Fosse, T E Mollnes, et al.
Pageof 41